Literature DB >> 7681364

Structure of the PI3K SH3 domain and analysis of the SH3 family.

S Koyama1, H Yu, D C Dalgarno, T B Shin, L D Zydowsky, S L Schreiber.   

Abstract

Src homology 3 (SH3) domains, which are found in many proteins involved in intracellular signal transduction, mediate specific protein-protein interactions. The three-dimensional structure of the SH3 domain in the p85 subunit of the phosphatidylinositol 3-kinase (PI3K) has been determined by multidimensional NMR methods. The molecule consists of four short helices, two beta turns, and two antiparallel beta sheets. The beta sheets are highly similar to corresponding regions in the SH3 domain of the tyrosine kinase Src, even though the sequence identity of the two domains is low. There is a unique 15 amino acid insert in PI3K that contains three short helices. There are substantial differences in the identity of the amino acids that make up the receptor site of SH3 domains. The results suggest that while the overall structures of the binding sites in the PI3K and Src SH3 domains are similar, their ligand binding properties may differ.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681364     DOI: 10.1016/0092-8674(93)90582-b

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  29 in total

1.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

3.  Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.

Authors:  Haiyan Wu; S Chandra Shekar; Rory J Flinn; Mirvat El-Sibai; Bijay S Jaiswal; K Ilker Sen; Vasantharajan Janakiraman; Somasekar Seshagiri; Gary J Gerfen; Mark E Girvin; Jonathan M Backer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

4.  Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation.

Authors:  K Q Hu; J Settleman
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

5.  Amyloid fibril formation by an SH3 domain.

Authors:  J I Guijarro; M Sunde; J A Jones; I D Campbell; C M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

6.  Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α Homodimer.

Authors:  Jaclyn LoPiccolo; Seung Joong Kim; Yi Shi; Bin Wu; Haiyan Wu; Brian T Chait; Robert H Singer; Andrej Sali; Michael Brenowitz; Anne R Bresnick; Jonathan M Backer
Journal:  J Biol Chem       Date:  2015-10-16       Impact factor: 5.157

7.  Interaction between PAK and nck: a template for Nck targets and role of PAK autophosphorylation.

Authors:  Z S Zhao; E Manser; L Lim
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

8.  Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.

Authors:  Shu-Yue Ren; Elisabeth Bolton; M Golam Mohi; Andrea Morrione; Benjamin G Neel; Tomasz Skorski
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  X-ray structure of the SH3 domain of the phosphoinositide 3-kinase p85β subunit.

Authors:  Shuai Chen; Yibei Xiao; Rajesh Ponnusamy; Jinzhi Tan; Jian Lei; Rolf Hilgenfeld
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-25

10.  Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain.

Authors:  R R Mattingly; A Sorisky; M R Brann; I G Macara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.